Sugammadex Amomed is a medicine used to reverse the effect of the muscle relaxants rocuronium and vecuronium. Muscle relaxants are medicines used during some types of operation to make the muscles relax, including the muscles that help the patient to breathe. Muscle relaxants make it easier for the surgeon to do the operation. Sugammadex Amomed is used to speed up the recovery from the muscle relaxant, usually at the end of the operation. Sugammadex Amomed can be used in adults who have received rocuronium and vecuronium, and in children aged 2 years or older who have received rocuronium. Sugammadex Amomed contains the active substance sugammadex and is a ‘generic medicine’. This means that Sugammadex Amomed contains the same active substance and works in the same way as a ‘reference medicine’ already authorised in the EU. The reference medicine for Sugammadex Amomed is called Bridion. For more information on generic medicines, see the question-and-answer document [here](https://www.ema.europa.eu/en/documents/medicine-qa/questions-answers-generic-medicines_en.pdf).
Therapeutic Indication
### Therapeutic indication Reversal of neuromuscular blockade induced by rocuronium or vecuronium. For the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.
Therapeutic Area (MeSH)
N/AATC Code
V03AB35
ATC Item
sugammadex
Pharmacotherapeutic Group
All other therapeutic products
Active Substance (Summary)
INN / Common Names
N/A| Substance | CAS | Monograph |
|---|---|---|
| sugammadex sodium | N/A | 舒更葡糖钠 |
EMA Name
Sugammadex Amomed
Medicine Name
Sugammadex Amomed
Aliases
N/ANo risk management plan link.